tradingkey.logo
搜索

Bausch + Lomb Corp

BLCO
添加自选
16.250USD
+0.220+1.37%
收盘 05/13, 16:00美东报价延迟15分钟
5.79B总市值
亏损市盈率 TTM

Bausch + Lomb Corp

16.250
+0.220+1.37%

关于 Bausch + Lomb Corp 公司

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corp简介

公司代码BLCO
公司名称Bausch + Lomb Corp
上市日期May 06, 2022
CEOSaunders (Brenton L)
员工数量13500
证券类型Ordinary Share
年结日May 06
公司地址520 Applewood Crescent
城市VAUGHAN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Canada
邮编L4K 4B4
电话19082552864
网址https://ir.bausch.com/
公司代码BLCO
上市日期May 06, 2022
CEOSaunders (Brenton L)

Bausch + Lomb Corp公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
100.10K
-13.65%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
88.03K
-13.60%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
78.42K
+2.05%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
60.37K
+13.25%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
100.10K
-13.65%
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
88.03K
-13.60%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
78.42K
+2.05%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
60.37K
+13.25%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Devices
1.92B
37.68%
OTC
1.83B
35.95%
Pharmaceuticals
1.08B
21.19%
Branded and other Generics
243.00M
4.76%
Other revenues
21.00M
0.41%
地区USD
名称
营收
占比
U.S. and Puerto Rico
2.55B
49.91%
Other
777.00M
15.23%
China
358.00M
7.02%
France
246.00M
4.82%
Japan
186.00M
3.65%
其他
988.00M
19.37%
业务
地区
业务USD
名称
营收
占比
Devices
1.92B
37.68%
OTC
1.83B
35.95%
Pharmaceuticals
1.08B
21.19%
Branded and other Generics
243.00M
4.76%
Other revenues
21.00M
0.41%

股东统计

更新时间: 5月9日 周六
更新时间: 5月9日 周六
持股股东
股东类型
持股股东
持股股东
占比
Bausch Health Companies Inc
87.07%
Deutsche Bank Securities Inc.
0.99%
Icahn Capital LP
0.98%
Oaktree Capital Management, L.P.
0.95%
D. E. Shaw & Co., L.P.
0.80%
其他
9.22%
持股股东
持股股东
占比
Bausch Health Companies Inc
87.07%
Deutsche Bank Securities Inc.
0.99%
Icahn Capital LP
0.98%
Oaktree Capital Management, L.P.
0.95%
D. E. Shaw & Co., L.P.
0.80%
其他
9.22%
股东类型
持股股东
占比
Corporation
87.07%
Hedge Fund
3.96%
Investment Advisor/Hedge Fund
3.36%
Investment Advisor
2.33%
Research Firm
1.66%
Individual Investor
0.57%
Family Office
0.23%
其他
0.83%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
249
40.30M
11.30%
-25.01M
2025Q4
247
42.63M
17.16%
+11.66K
2025Q3
260
42.62M
19.43%
+3.57M
2025Q2
253
39.09M
18.05%
+715.03K
2025Q1
249
38.33M
16.53%
-19.93M
2024Q4
239
35.61M
16.96%
-2.09M
2024Q3
234
37.72M
16.36%
-3.49M
2024Q2
237
40.61M
17.42%
+3.09M
2024Q1
226
37.49M
18.08%
-25.96M
2023Q4
216
38.90M
17.69%
-4.13M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Bausch Health Companies Inc
310.45M
87.43%
--
--
Mar 24, 2025
Deutsche Bank Securities Inc.
3.45M
0.97%
-50.00K
-1.43%
Dec 31, 2025
Icahn Capital LP
3.50M
0.99%
--
--
Dec 31, 2025
Oaktree Capital Management, L.P.
3.38M
0.95%
+137.30K
+4.23%
Dec 31, 2025
D. E. Shaw & Co., L.P.
2.85M
0.8%
+239.63K
+9.19%
Dec 31, 2025
GoldenTree Asset Management, LP
2.66M
0.75%
--
--
Dec 31, 2025
Silver Point Capital, L.P.
2.56M
0.72%
--
--
Dec 31, 2025
Caspian Capital LP
2.00M
0.56%
+1.35M
+207.55%
Dec 31, 2025
Davidson Kempner Capital Management LP
1.94M
0.55%
+959.24K
+97.83%
Dec 31, 2025
Glenview Capital Management, LLC
1.65M
0.47%
+100.00K
+6.44%
Dec 31, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Ballast Small/Mid Cap ETF
1.4%
Invesco RAFI Developed Mkts ex-US SM ETF
0.03%
BNY Mellon US Small Cap Core Equity ETF
0.03%
Schwab Fundamental International Small Equity ETF
0%
Goldman Sachs MarketBeta US 1000 Equity ETF
0%
Invesco Zacks Mid-Cap ETF
0%
QRAFT AI-Enhanced US Large Cap ETF
0%
AltShares Event-Driven ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
BNY Mellon US Mid Cap Core Equity ETF
0%
查看更多
Ballast Small/Mid Cap ETF
占比1.4%
Invesco RAFI Developed Mkts ex-US SM ETF
占比0.03%
BNY Mellon US Small Cap Core Equity ETF
占比0.03%
Schwab Fundamental International Small Equity ETF
占比0%
Goldman Sachs MarketBeta US 1000 Equity ETF
占比0%
Invesco Zacks Mid-Cap ETF
占比0%
QRAFT AI-Enhanced US Large Cap ETF
占比0%
AltShares Event-Driven ETF
占比0%
DFA Dimensional International Core Equity 2 ETF
占比0%
BNY Mellon US Mid Cap Core Equity ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI